Final Belgian list:

Final Belgian list:
DAXAS
(Last update 07/04/2014)
Active substance
BRENTUXIMAB VEDOTINE
RIOCIGUAT
LARONIDASE
FORBETAPIR (F-18) Q.S.
OFATUMUMAB 20.00 MG/ML
NELARABINE 5.00 MG/ML
ANTITHROMBIN ALFA
TERIFLUNOMIDE
BELIMUMAB
MIRABEGRON
NEISSERIA MENINGITIDES B, RECOMBINANT,
COMPONENT, ADSORBED Q.S.
COLESTILAN
BOSUTINIB (MONOHYDRATE) 100.00 MG
ACLIDINIUM (BROMURE)
VORTIOXETINE
VANDETANIB
HISTAMINE DIHYDROCHLORIDE
VARENICLINE (TARTRATE)
ETHINYLESTRADIOL 35.00 MCG, CYPROTERONE
ACETATE 2.00 MG
C1-INHIBITOR 500.00 IU
ETHINYLESTRADIOL 35.00 MCG, CYPROTERONE
ACETATE 2.00 MG
CLEVIDIPINE BUTYRATE
LINACLOTIDE
COPPER (64-CU) CHLORIDE Q.S.
DECITABINE
ROFLUMILAST 500.00 MCG
ETHINYLESTRADIOL 35.00 MCG, CYPROTERONE
ACETATE 2.00 MG
ROFLUMILAST
DEFITELIO
DEFIBROTIDE
Gentium
DIACOMIT
STIRIPENTOL
ETHINYLESTRADIOL 35.00 MCG, CYPROTERONE
ACETATE 2.00 MG
BIOCODEX
PASS
New biological, authorised under
exceptional circumstances
Conditional auth
BAYER N.V.
PASS
marketing name
ADCETRIS
ADEMPAS
ALDURAZYME
AMYVID
ARZERRA
ATRIANCE
ATRYN
AUBAGIO
BENLYSTA
BETMIGA
BEXSERO
BINDREN
BOSULIF
BRETARIS GENUAIR
BRINTELLIX
CAPRELSA
CEPLENE
CHAMPIX
CHLOE
CINRYZE
CLAUDIA - 35
CLEVIPREX
CONSTELLA
CUPRYMINA
DACOGEN
DALIRESP
DAPHNE
DIANE-35
MAH
TAKEDA GLOBAL R&D CENTRE (EUROPE) LTD
Bayer Pharma AG
GENZYME EUROPE B.V.
ELI LILLY NEDERLAND BV
GLAXO GROUP LTD
GLAXO GROUP LTD
GTC BIOTHERAPEUTICS UK LIMITED
SANOFI-AVENTIS GROUPE
GLAXO GROUP LTD
ASTELLAS PHARMA EUROPE B.V.
Reason on list
New AS, Cond Auth, PASS
New AS
Auth under excep circumstances, PASS
New AS
Conditional auth, PASS
Auth under excep circumstances
Auth under excep circumstances, PASS
New AS
New AS
New AS
NOVARTIS VACCINES & DIAGNOSTICS S.R.L.
New AS
NOVARTIS VACCINES & DIAGNOSTICS S.R.L.
PFIZER LIMITED
ALMIRALL S.A
H. LUNDBECK A/S
ASTRAZENECA AB
MEDA AB
PFIZER LIMITED
New AS
New AS, Cond Auth, PASS
New AS, PASS
New AS
New AS, Cond Auth
Auth under excep circumstances
PASS
MITHRA PHARMACEUTICALS S.A.
PASS
VIROPHARMA BVBA
PASS
SANDOZ N.V.
PASS
THE MEDICINES COMPANY UK LTD
ALMIRALL S.A
SPARKLE S.R.L
JANSSEN-CILAG INTERNATIONAL NV
NYCOMED GMBH
New AS
New AS
New AS
New AS
PASS
MITHRA PHARMACEUTICALS S.A.
PASS
NYCOMED GMBH
DIFICLIR
EDARBI
EDURANT
EKISTOL
EKLIRA GENUAIR
ELAPRASE
ELIQUIS
ELISAMYLAN 35
ELVANSE / TYVENSE
ENUREV BREEZHALER
EPERZAN
ERIVEDGE
ESBRIET
EURARTESIM
EVARREST
FIDAXOMICIN
AZILSARTAN MEDOXOMIL (POTASSIUM)
RILPIVIRINE (HYDROCHLORIDE)
CILOSTAZOL
ACLIDINIUM (BROMURE)
IDURSULFASE
APIXABAN
ETHINYLESTRADIOL 35.00 MCG, CYPROTERONE
ACETATE 2.00 MG
LISDEXAMPHETAMINE
GLYCOPYRRONIUM (BROMIDE)
ALBIGLUTIDE
VISMODEGIB
PIRFENIDONE
PIPERAQUINE TETRAPHOSPHATE (TETRAHYDRATE) ,
DIHYDROARTEMISININ (DHA)
ASTELLAS PHARMA EUROPE B.V.
TAKEDA GLOBAL R&D CENTRE (EUROPE) LTD
JANSSEN-CILAG INTERNATIONAL NV
???
ALMIRALL S.A.
SHIRE HUMAN GENETIC THERAPIES AB
BRISTOL MYERS SQUIBB/PFIZER EEIG
New AS
New AS
New AS
Outcome Referral Art 31, PASS
New AS, PASS
Auth under excep circumstances
New AS
MYLAN BVBA/SPRL
PASS
BRYSTOL MYERS SQUIBB/ PFIZER EEIG
NOVARTIS EUROPHARM LIMITED
GlaxoSmithKline Trading Services Limited
ROCHE REGISTRATION LIMITED
INTERMUNE EUROPE LTD
New AS
New AS, PASS
New AS
New AS, Cond Auth
New AS, PASS
SIGMA-TAU INDUSTRIE FARMAC. RIUNITE SPA
New AS, PASS
FIBRINOGEN, HUMAN Q.S., THROMBIN, HUMAN Q.S. OMRIX BIOPHARMACEUTICALS N.V.
New Biological
EVOLTRA
EXJADE
EYLEA
FAMPYRA
FIRDAPSE
FLUENZ
FLUENZ TETRA
FORXIGA
FYCOMPA
GILENYA
GIOTRIF
ENOFOVIR DISOPROXIL (FUMARATE) , EMTRICITABINE
, RILPIVIRINE (HYDROCHLORIDE)
CLOFARABINE
DEFERASIROX
AFLIBERCEPT
FAMPRIDINE
AMIFAMPRIDINE (PHOSPHATE)
INFLUENZA VIRUS, LIVE, ATTENUATED Q.S.
INFLUENZA VIRUS (LIVE, ATTENUATED Q.S., NASAL)
DAPAGLIFLOZIN (PROPANEDIOL MONOHYDRATE)
PERAMPANEL
FINGOLIMOD (HYDROCHLORIDE) 0.50 MG
AFATINIB
GLYBERA
ALIPOGENE TIPARVOVEC Q.S.
UNIQURE BIOPHARMA B.V
GRASTOFIL
FILGASTRIM
ETHINYLESTRADIOL 35.00 MCG, CYPROTERONE
ACETATE 2.00 MG
ERIBULIN (MESYLATE) 0.44 MG/ML
Apotex Europe
Auth under excep circumstances
PASS
New AS
New AS, Cond Auth
Auth under excep circumstances, PASS
New AS
New AS
New AS
New AS
New AS, PASS
New AS
New AS, Auth under excep
circumstances, PASS
New Biological
3DDD PHARMA N.V.
PASS
EISAI LIMITED
New AS
EVIPLERA
GRATIELLA 35
HALAVEN
GILEAD SCIENCES LTD
New AS
GENZYME EUROPE B.V.
NOVARTIS EUROPHARM LIMITED
BAYER AG
BIOGEN IDEC LTD
BIOMARIN EUROPE LTD
MEDIMMUNE LLC
MEDIMMUNE LLC
BRISTOL MYERS SQUIBB/ASTRAZENECA EEIG
EISAI EUROPE LTD
NOVARTIS EUROPHARM LIMITED
Boehringer Ingelheim International
HEXACIMA
HEXYON
Diphtheria, tetanus, pertussis (acellular, component),
hepatitis B (rDNA), poliomyelitis (inactivated) and
SANOFI PASTEUR SA
Haemophilus influenzae type B conjugate vaccine
(adsorbed)
Diphtheria, tetanus, pertussis (acellular, component),
hepatitis B (rDNA), poliomyelitis (inactivated) and
SANOFI PASTEUR MSD
Haemophilus influenzae type B conjugate vaccine
(adsorbed)
New Biological
New Biological
HIZENTRA
IMMUNOGLOBULIN HUMAN NORMAL 200.00 MG/ML BIOCLS GMBH
New Biological
HYQVIA
IMMUNOGLOBULIN HUMAN NORMAL 100.00 MG/ML BAXTER INNOVATIONS GMBH
New Biological
ICLUSIG
ILARIS
IMNOVID
(POMALIDOMIDE
CELGENE)
PONATINIB (HYDROCHLORIDE)
CANAKINUMAB
ARIAD PHARMA LTD
NOVARTIS EUROPHARM LIMITED
New AS
Auth under excep circumstances, PASS
POMALIDOMIDE
CELGENE EUROPE LIMITED
New AS, PASS
IMVANEX
INCIVO
INCRELEX
INCRESYNC
INFLECTRA
INFLUSPLIT TETRA
INLYTA
INVIRASE
INVOKANA
IOA
Modified Vaccinia Ankara virus - Bavarian Nordic
(MVA-BN) live virus
TELAPREVIR
MECASERMIN
ALOGLIPTIN/PIOGLITAZONE
NFLIXIMAB
Influenza virus inactivated split virion
AXITINIB
SAQUINAVIR (MESILATE)
CANAGLIFLOZIN
BAVARIAN NORDIC A/S
JANSSEN-CILAG INTERNATIONAL NV
IPSEN PHARMA
Takeda Pharma
HOSPIRA UK LTD
GLAXO GROUP LTD
PFIZER LIMITED
ROCHE REGISTRATION LIMITED
Janssen-Cilag International N.V.
New AS, Auth under excep
circumstances
New AS
Auth under excep circumstances, PASS
New AS
New Biological
Biological
New AS
PASS
New AS
PASS
IPREZIV
JAKAVI
JAYDESS
MERCK SHARP & DOHME
NOMOGESTROL ACETATE / ESTRADIOL HEMIHYDRATE
AZILSARTAN MEDOXOMIL (POTASSIUM)
TAKEDA GLOBAL R&D CENTRE (EUROPE) LTD
RUXOLITINIB (PHOSPHATE)
NOVARTIS EUROPHARM LIMITED
LEVONORGESTREL 13.50 MG
BAYER N.V.
JENTADUETO
METFORMIN HYDROCHLORIDE , LINAGLIPTIN
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
New AS
JETREA
JEVTANA
KADCYLA
KALYDECO
KRYSTEXXA
OCRIPLASMIN
CABAZITAXEL
TRASTUZUMAB EMTANSINE
IVACAFTOR
PEGLOTICASE
THROMBOGENICS NV
SANOFI-AVENTIS GROUPE
Roche Registration Ltd
VERTEX PHARMACEUTICALS LIMIT
SAVIENT PHARMA IRELAND LIMITED
New AS
New AS
New AS
New AS, PASS
New AS, PASS
New AS
New AS, PASS
PASS
LACTEST
LATUDA
LEMTRADA
LIBERTEK
GASILOXE
LURASIDONE
ALEMTUZUMAB
ROFLUMILAST
Lactest S.L. / Venter Pharma S.L.
Takeda Pharma A/S
GENZYME THERAPEUTICS LTD
NYCOMED GMBH
LOJUXTA
LOMITAPIDE (MESYLATE)
AEGERION PHARMACEUTICALS
LONQUEX
LYXUMIA
MACI
NAGLAZYME
NEURACEQ
LIPEGFILGRASTIM
LIXISENATIDE
CHONDROCYTES, AUTOLOGOUS CULTURED Q.S.
GALSULFASE
FLORBETABEN (18F)
PROTEOLYTIC ENZYMES (CONCENTRATE) ENRICHED IN
BROMELAIN
NEISSERIA MENINGITIDES A+C+W+Y,
POLYSACCHARIDE CONJ. TO TETANUS TOXOID Q.S.
Turoctocog alfa
CATRIDECACOG
BELATACEPT
EPTOTERMIN ALFA
TEVA PHARMA BV
SANOFI-AVENTIS GROUPE
GENZYME EUROPE B.V.
BIOMARIN EUROPE LTD
Piramal Imaging GmbH
New AS
New AS
New Biological
PASS
New AS, Auth under excep
circumstances
New AS, PASS
New AS
New AS
Auth under excep circumstances, PASS
New AS
TEVA PHARMA GMBH
New AS, PASS
GLAXOSMITHKLINE BIOLOGICALS S.A.
New AS, PASS
NOVO NORDISK A/S
NOVO NORDISK A/S
BRISTOL-MYERS SQUIBB PHARMA EEIG
OLYMPUS BIOTECH LTD
NEXOBRID
NIMENRIX
NOVOEIGHT
NOVOTHIRTEEN
NULOJIX
OPGENRA
OPSUMIT
OPTIMARK
ORPHACOL
OSSEOR
OVALEAP
PANDEMRIX
PERJETA
PICATO
PIXUVRI
PLETAL
PRIALT
PROTELOS
MACITENTAN
Actelion Registration Ltd
GADOVERSETAMIDE
CHOLIC ACID
STRONTIUM RANELATE
FOLLITROPIN ALPHA
INFLUENZA VIRUS (INACTIVATED) Q.S.
PERTUZUMAB
INGENOL MEBUTATE
PIXANTRONE (DIMALEATE)
CILOSTAZOL
ZICONOTIDE (ACETATE)
STRONTIUM RANELATE
MALLINCKRODT MEDICAL GMBH
LABORATOIRES CTRS
SERVIER, LES LABORATOIRES
Teva Pharma
GLAXOSMITHKLINE BIOLOGICALS S.A.
ROCHE REGISTRATION LIMITED
LEO PHARMA A/S
CTI LIFE SCIENCES LTD
???
EISAI LIMITED
SERVIER, LES LABORATOIRES
New AS
New AS
New AS
PASS
New AS
PASS
Auth under excep circumstances
PASS
New Biological
PASS
New AS
New AS
New AS, Cond Auth
Outcome Referral Art 31, PASS
Auth under excep circumstances, PASS
PASS
PROVENGE
AUTOLOGOUS PERIPHERAL BLOOD MONONUCLEAR
CELLS ACTIVATED WITH PAP-GM-CS Q.S.
DENDREON UK LIMITED
New AS, PASS
RELVAR ELLIPTA
REMSIMA
REPLAGAL
REVESTIVE
RIENSO
Fluticasone furoate/vilanterol trifenatate
INFLIXIMAB
AGALSIDASE ALFA
TEDUGLUTIDE
FERUMOXYTOL
Glaxo Group Ltd
CELLTRION HEALTHCARE HUNGARY KFT.
SHIRE HUMAN GENETIC THERAPIES AB
NYCOMED DANMARK APS
TAKEDA PHARMA A/S
New AS, PASS
New Biological
Auth under excep circumstances, PASS
New AS, PASS
New AS
RYZODEG
SEEBRI BREEZHALER
SELINCRO
SIGNIFOR
SIRTURO
SOMATROPIN
BIOPARTNERS
SOVALDI
SPEDRA
STIVARGA
INSULIN ASPART 30.00 UML, INSULIN DEGLUDEC
70.00 UML
GLYCOPYRRONIUM (BROMIDE)
NALMEFENE (HYDROCHLORIDE DIHYDRATE)
PASIREOTIDE (DIASPARTATE)
BEDAQUILINE
SOMATROPIN
NOVO NORDISK A/S
New AS
NOVARTIS EUROPHARM LIMITED
LUNDBECK A/S
NOVARTIS EUROPHARM LIMITED
Janssen-Cilag International N.V.
New AS, PASS
New AS
New AS
New AS, conditional auth
BIOPARTNERS
New Biological
Gilead Sciences International Limited
VIVUS BV
BAYER AG
New AS
New AS
New AS
GILEAD SCIENCES LTD
New AS
GLAXOSMITHKLINE TRADING SERVICES LIMITED
New AS
NORDIC GROUP BV
New AS, PASS
ViiV Healthcare UK Limited
NOVARTIS EUROPHARM LIMITED
New AS
New AS, PASS
TIVICAY
TOVANOR BREEZHALER
SOFOSBUVIR
AVANAFIL
REGORAFENIB
TENOFOVIR DISOPROXIL (FUMARATE) ,
EMTRICITABINE , ELVITEGRAVIR , COBICISTAT
DABRAFENIB
TEGAFUR , GIMERACIL , OTERACIL
(MONOPOTASSIUM)
DOLUTEGRAVIR
GLYCOPYRRONIUM (BROMIDE)
TRAJENTA
LINAGLIPTIN
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
New AS
TRESIBA
TROBALT
TYBOST
TYGACIL
TYSABRI
TYVERB
INSULIN DEGLUDEC
RETIGABINE
COBICISTAT
TIGECYCLINE
NATALIZUMAB
LAPATINIB (DITOSYLATE MONOHYDRATE)
INDACATEROL (MALEATE) 85.00 MCG/DO,
GLYCOPYRRONIUM (BROMIDE) 43.00 MCG/DO
PANITUMUMAB 20.00 MG/ML
TOCOPHEROL D-ALPHA (AS TOCOFERSOLAN)
INFLUENZA VIRUS (INACTIVATED) Q.S.
BOCEPREVIR
ALOGLYPTIN / METFORMIN
ALOGLYPTIN
ELVITEGRAVIR
FACTOR VIII HUMAN 1000.00 IU, FACTOR VON
WILLEBRAND 2400.00 IU
EVEROLIMUS
NOVO NORDISK A/S
GLAXO GROUP LTD
Gilead Sciences
PFIZER LIMITED
BIOGEN IDEC LTD
GLAXO GROUP LTD
New AS
New AS
New AS
PASS
PASS
Conditional auth
NOVARTIS EUROPHARM LIMITED
PASS
AMGEN EUROPE BV
ORPHAN EUROPE SARL
BAXTER INNOVATIONS GMBH
MERCK SHARP & DOHME LTD
Takeda Pharma
Takeda Pharma
Gilead Sciences International Ltd
Conditional auth
Auth under excep circumstances, PASS
New AS
New AS
New AS
New AS
New AS
TEVA PHARMA BV
New Biological
NOVARTIS EUROPHARM LIMITED
Conditional auth
STRIBILD
TAFINLAR
TEYSUNO
ULTIBRO BREEZHALER
VECTIBIX
VEDROP
VEPACEL
VICTRELIS
VIPDOMET
VIPIDIA
VITEKTA
VONCENTO
VOTUBIA
Bayer Pharma AG
TEVA PHARMA BV
ASTELLAS PHARMA EUROPE B.V.
CROMA-PHARMA GMBH
BRISTOL-MYERS SQUIBB PHARMA EEIG
PHARMA MAR SA
SANOFI-AVENTIS GROUPE
ROCHE REGISTRATION LIMITED
Auth under excep circumstances, New
AS, PASS
Auth under excep circumstances
New AS, Cond Auth
PASS
New biological
New AS
New AS
New AS
PASS
New AS
New AS
New AS, PASS
Auth under excep circumstances
New AS
New AS
ASTRAZENECA AB
New AS
VYNDAQEL
TAFAMIDIS (MEGLUMINE)
PFIZER LIMITED
XAGRID
XALKORI
XARELTO
XGEVA
XIAPEX
XIGDUO
XOFIGO
XOTERNA BREEZHALER
XTANDI
YELLOX
YERVOY
YONDELIS
ZALTRAP
ZELBORAF
XAGRID
CRIZOTINIB
RIVAROXABAN 10.00 MG
DENOSUMAB
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
DAPAGLIFLOZIN/METFORMIN
Radium Ra 223 dichloride
INDACATEROL / GLYCOPYRRONIUM
ENZALUTAMIDE
BROMFENAC (SODIUM SESQUIHYDRATE)
IPILIMUMAB
TRABECTEDIN
AFLIBERCEPT
VEMURAFENIB
CEFTAROLINE FOSAMIL (ACETIC ACID SOLVATE
MONOHYDRATE)
SHIRE PHARMACEUTICAL CONTRACTS LTD
PFIZER LIMITED
BAYER SCHERING PHARMA AG
AMGEN EUROPE BV
AUXILIUM UK LIMITED
ZINFORO
ZOELY
ZYTIGA
THERAMEX S.r.l.
NOMOGESTROL ACETATE / ESTRADIOL HEMIHYDRATE
ABIRATERONE ACETATE
JANSSEN-CILAG INTERNATIONAL NV
NOTE
In Red
in Black
in blue
in grey
New AS
New Biological
PASS
Bristol-Myers Squibb/AstraZeneca EEIG
commercialised / commercialisé /
gecommercialiseerd
not commercialised / pas commercialisé / niet
gecommercialiseerd
info not yet available / info non disponible / info niet
beschikbaar
New addition of this month / nouvelle addition de ce
mois / nieuwe toevoeging van deze maand
nouvelle substance active / nieuw actief bestanddeel
nouveau médicament biologique / nieuwe biologische
geneesmiddel
Etude de sécurité post-autorisation / post-autorisatie
veiligheidsstudies
PASS
New AS
Conditional auth
Auth under excep
circumstances
Autorisé sous certaines conditions / vergund onder
bepaalde voorwaarden
autorisé sous circonstances exceptionnelles / vergund
onder uitzonderlijke omstandigheden
Product informations / informations
informations
sursur
lesles
produits
produits/productinformatie
/ produkten informaties
http://www.fagg-afmps.be/search?language=fr&search_field=notice